FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.180
-0.060 (-4.84%)
At close: Oct 5, 2026, 4:00 PM EDT
1.200
+0.020 (1.69%)
After-hours: Oct 5, 2026, 7:35 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $8.21 million as of October 5, 2026. Its market cap has decreased by -64.32% in one year.
Market Cap
8.21M
Enterprise Value
6.16M
1-Year Change
-64.32%
Ranking
Category
Stock Price
$1.18
ChartMarket Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $8.21M, a decrease of -99.13%. That is a compound annual growth rate of -82.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 8.21M | -45.13% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 9.48M |
| Immuron | 8.98M |
| Aprea Therapeutics | 8.75M |
| Traws Pharma | 8.74M |
| Longeveron | 8.23M |
| XTL Biopharmaceuticals | 8.16M |
| Azitra | 8.00M |
| Soligenix | 7.95M |